Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

CarrerasLeaders · Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

HORIZONStatus: SIGNED1 January 202331 December 2028EU funding €2,292,480Call HORIZON-MSCA-2021-COFUND-01

CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leukaemia Research Institute (IJC), an independent, non-profit biomedical research institute that is part of the Government of Catalonia network of Research Centres (CERCA). IJC is the first European institute exclusively devoted to leukaemia and other malignant blood diseases. The aim of the programme is to fund 16 excellent postdoctoral researchers for a period of 36 months. The selection of the fellows is merit-based, founded on peer review in an open and transparent selection procedure. Carrerasleaders is addressed to boost career perspective of researchers from a three-dimensional perspective: leadership, independence, and consolidation.This is a world-wide unique postdoctoral program that covers the entire spectrum of research and innovation in blood cancers and goes from understanding disease biology to the implementation of products and processes in the market and into the clinical practice through the development of a global translational approach. Applicants will have complete freedom of research choice within the scope of blood cancers and will be offer highly attractive working conditions and a healthy, inspiring and creative working environment. CarrerasLeaders is designed based on the following objectives: 1. Training the next generation of scientist leaders to advance on the cure of blood cancers, multiplying each one’s skills sets and networks via targeted Career Development Plans and mentoring.2.Improve the quality of blood cancers postdoctoral research training, more targeted addressed to the researchers and societal needs. 3.Enhanced cooperation and transfer knowledge between sectors and disciplines.4.Enable outstanding junior researchers to develop their research careers to an advanced and more independent level in a leading institution such as IJC. 5.Increase the competitiveness of the IJC blood cancers community

Consortium · 46 organisations

coordinator

FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

ES · €2,292,480

associatedPartner

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DE

associatedPartner

UNIVERSITY OF SHARJAH

AE

associatedPartner

UNIVERSIDAD POMPEU FABRA

ES

associatedPartner

KITHER BIOTECH SRL

IT

associatedPartner

MILTENYI BIOTEC BV & CO KG

DE

associatedPartner

APPLIED NANOPARTICLES SL

ES

associatedPartner

Fundació Internacional Josep Carreras

ES

associatedPartner

FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA

ES

associatedPartner

GENOME RESEARCH LIMITED LBG

UK

associatedPartner

USTAV MOLEKULARNI GENETIKY AV CR V.V.I.

CZ

associatedPartner

ANAXOMICS BIOTECH SL

ES

associatedPartner

Leadership Sculptor GmbH

DE

associatedPartner

IBM RESEARCH GMBH

CH

associatedPartner

Genome Identification Diagnostics GmbH

DE

associatedPartner

UNIVERSITY OF NEWCASTLE UPON TYNE

UK

associatedPartner

MEDIZINISCHE HOCHSCHULE HANNOVER

DE

associatedPartner

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE

PT

associatedPartner

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

CH

associatedPartner

UNIVERSITE LIBRE DE BRUXELLES

BE

associatedPartner

EUROPEAN HEMATOLOGY ASSOCIATION

NL

associatedPartner

APPLIED RESEARCH USING OMIC SCIENCES SL

ES

associatedPartner

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES

associatedPartner

AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

ES

associatedPartner

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

US

associatedPartner

NEW YORK UNIVERSITY

US

associatedPartner

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

ES

associatedPartner

Gavin Lucas

ES

associatedPartner

ZECLINICS SL

ES

associatedPartner

GenomeScan B.V.

NL

associatedPartner

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE

associatedPartner

FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR)

CH

associatedPartner

MESOESTETIC PHARMA GROUP S.L.

ES

associatedPartner

HUMANITAS MIRASOLE SPA

IT

associatedPartner

Asociación Española Contra el Cáncer

ES

associatedPartner

UNIVERSITETET I OSLO

NO

associatedPartner

SCIENSEED SL

ES

associatedPartner

SEMMELWEIS EGYETEM

HU

associatedPartner

QUIMATRYX SL

ES

associatedPartner

IMMAGINA BIOTECHNOLOGY SRL

IT

associatedPartner

FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER

ES

associatedPartner

International Society for Experimental Hematology

US

associatedPartner

ONECHAIN IMMUNOTHERAPEUTICS S.L.

ES

associatedPartner

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE

associatedPartner

NOVOGENE UK COMPANY LIMITED

UK

associatedPartner

MLL MUNCHNER LEUKAMIELABOR GMBH

DE

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.